A new study commissioned by AbbVie and prepared by HTANALYSTS has found that people on the ‘front line’ of caring for someone with advanced Parkinson’s disease secure the most significant gains when patients living with the condition can access standard-of-care treatments. …
Australian study finds families gain the most with treatment of advanced Parkinson’s disease
March 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Just in case they didn't get the message, Mark Butler has reminded them of the Government's view
July 7, 2026 - - Latest News -
Australian Healthcare Associates retains deal to administer the CSO funding pool through 2029
July 7, 2026 - - Latest News -
Just another attempt to create a new excuse to avoid a meaningful discussion about change
July 7, 2026 - - Latest News -
Australia must keep development manufacturing and jobs here to secure health and economic benefits
July 7, 2026 - - Latest News -
Brandon Capital secures landmark Novartis acquisition of Myricx Bio
July 6, 2026 - - Latest News -
Vitex opens $250 million pharmaceutical manufacturing facility in Western Sydney
July 6, 2026 - - Latest News -
Early clinical imaging shows Syntara candidate reduces brain inflammation in people at high risk of Parkinson’s
July 6, 2026 - - Australian Biotech